Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy.
Eur Respir J. 2021 Jun 10;57(6):2100166. doi: 10.1183/13993003.00166-2021. Print 2021 Jun.
Eur Respir J. 2021.
PMID:33632798
没有抽象可用。